Dr. Michael George Pfeil Neimkin, MD

Dr. Neimkin practices at Digestive Healthcare of Georgia Endoscopy Center Mountainside in Atlanta, Georgia.

Dr. Neimkin's NPI, 1912225392, was assigned on May 11, 2010. Dr. Neimkin graduated from University of Alabama School of Medicine in 2010. Dr. Neimkin holds Georgia license 76141.

Dr. Neimkin's primary practice is Digestive Healthcare of Georgia Endoscopy Center Mountainside, at 3280 Howell Mill NW Rd, Atlanta, GA 30327 in Fulton County. The practice phone is (404) 603-3543.

Dr. Neimkin's primary practice is Digestive Healthcare of Georgia Endoscopy Center Mountainside in Atlanta, Georgia. Dr. Neimkin is also affiliated with Northside Hospital Atlanta. Dmand AI also links Dr. Neimkin to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Neimkin practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmic plastic and reconstructive surgery is Dr. Neimkin's primary specialty in the NPI Registry, under taxonomy code 207WX0200X. Dmand AI has Dr. Neimkin's licenses on file in 2 states: Georgia and Missouri.

CMS data shows 943 Medicare services from Dr. Neimkin across 10 procedure codes in 2024, for 337 Medicare patients. Medicare paid $103,122 for them.

CMS counts 337 Medicare patients who saw Dr. Neimkin in 2024. The largest group is 65 to 74, with 174 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Neimkin's median patient age at 66, with 61% women.

In 2024, Dr. Neimkin wrote 715 Medicare Part D claims for 283 patients. 96% of them were for generic drugs. CMS names the drug for 679 of them, across 10 drugs with 11 or more claims each, at $6,852 in total drug cost. In 2023, CMS named 639 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Neimkin for performance year 2024, reported individually. Dr. Neimkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 34 procedures of melanoma (skin cancer) excision by Dr. Neimkin, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Neimkin, published from 2017 to 2019. 2019 was the busiest year, with 3. The most frequent topics are Blepharoplasty, Eyelids and Suture Techniques. Dr. Neimkin has published most often in Ophthalmic Plast Reconstr Surg. Dr. Neimkin's most frequent co-authors are Zachary Modest Bodnar, MD, Michael A. Albert, MD and Robi Nicolas Maamari, MD.

CMS Open Payments shows 60 general payments to Dr. Neimkin from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Horizon Pharma plc paid the most, $570.

Dr. Neimkin graduated from University of Alabama School of Medicine in 2010.